Why Pharmacy and Poisons Board Is Stopping Use, Sale of Falsified Cancer Drud Detected in Kenyan Markets

The Pharmacy and Poisons Board CEO Fred Siyoi has warned Kenyans against the use of falsified Herceptin 440 mg (Trastuzumab 440 mg) to treat breast cancer.

Read Full Article

Add your comment here

This site uses Akismet to reduce spam. Learn how your comment data is processed.